This National Institute for Health and Care Excellence (NICE) guideline covers diagnosing and managing glaucoma in people aged 18 and over. It aims to address uncertainty and variation in clinical practice by giving clear recommendations on testing for chronic open angle glaucoma (COAG) and ocular hypertension (OHT) and on effective diagnosis, treatment and monitoring to stop these conditions progressing. This has the potential to prevent more people from going blind.
The guidance covers:
Once diagnosed, people with COAG need lifelong monitoring so that any progression of visual damage can be detected. Once lost, sight cannot be restored, and controlling the condition, together with prevention, or at least minimisation of ongoing damage, is crucial to maintaining a sighted lifetime.
Because uncertainty and variation exist in clinical practice this guideline seeks to give clear recommendations on testing for and diagnosing COAG and OHT, and on effective monitoring and treatment to prevent these conditions progressing. By implementing this guideline more people will be prevented from going blind.
You can read the guideline on NICE's website.